News

ORforglipron is a Experimental drug a small (non-peptide) oral agonist of the GLP-1 receptor oral, which does not require ...
Medically reviewed by Kelly Wood, MD Zepbound (tirzepatide) is a once-a-week injectable weight-loss medication. It helps ...
Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...
Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.
Eli Lilly is suing four telehealth companies that prescribe compounded versions of the pharmaceutical company's weight loss medications. Lilly filed four lawsuits on Wednesday claiming telehealth ...
Ascletis's news arrives shortly after Eli Lilly reported favourable Phase III weight loss data for its oral GLP-1RA, ...
MetaVia (MTVA) reported additional top-line results from the multiple ascending dose Part 2 of its Phase 1 clinical trial of DA-1726, a novel, ...
Scholar Rock Holding Corporation's apitegromab shows promise for SMA treatment, aims for 2025 launch. Click for my updated ...
In addition, the Trump administration decided to punt — for now — instead of address the hot topics of coverage for glucagon-like peptide 1 (GLP-1) agonist weight-loss drugs and the use of ...
A federal judge sided with the Trump administration Thursday, clearing the way for a policy that requires people in the U.S. illegally to register with the federal government and marking another ...
The Trump administration has reportedly frozen $790 million in federal funding at Northwestern. The freeze affects grants from agencies like defense, agriculture, and health and human services.
President Trump on Wednesday ordered his administration to repeal a Biden-era rule restricting water flow from shower heads. “In my case, I like to take a nice shower to take care of my ...